Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...

But the FDA under the new Trump administration is already starting to look dramatically different. It’s hard to keep track of ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

Makary, a former Johns Hopkins University surgeon and author, will take over as commissioner of food and drugs at the FDA and ...